» Articles » PMID: 31509005

Characterizing Covariant Trajectories of Individuals at Clinical High Risk for Psychosis Across Symptomatic and Functional Domains

Abstract

Objective: The authors sought to characterize differences in outcomes among help-seeking individuals at clinical high risk for psychosis by identifying covariant longitudinal patterns of symptoms and functioning.

Methods: Group-based multitrajectory modeling was applied to longitudinal ratings of four symptom domains (positive, negative, disorganized, general) and general functioning among clinical high-risk individuals in an initial discovery sample (N=422). An independent sample (N=133) was used to test replicability.

Results: Three trajectory groups were identified among clinical high-risk individuals in the discovery sample: group 1 (30%) exhibited substantial improvement across all domains, with half reaching positive outcomes for both functioning and positive symptoms; group 2 (49%) exhibited moderate impairments across domains, with approximately one-quarter meeting criteria for positive outcomes; the remaining participants (group 3; 22%) exhibited consistent levels of severe impairment across domains and did not experience positive outcomes. These trajectory groups and remission patterns were replicated in an independent sample.

Conclusions: Replicable subgroups of help-seeking clinical high-risk cases can be ascertained based on distinctive profiles of change over time in symptoms and functioning. Within each of the three identified subgroups, similar patterns of change (i.e., rapid, moderate, or no improvement) were observed across the four symptom domains and functioning. This consistency of change over time across domains within each subgroup is a novel observation supporting the syndrome consistency of clinical high-risk symptoms and signs. The observed trajectory subgroups are suggestive of different degrees of need for clinical interventions, ranging from minimal or supportive for about one-third of cases to increasingly intensive among the remainder.

Citing Articles

Longitudinal Trajectories of Premorbid Social and Academic Adjustment in Youth at Clinical High Risk for Psychosis: Implications for Conversion.

Cowan H, Mittal V, Addington J, Bearden C, Cadenhead K, Cornblatt B Schizophr Bull. 2024; 51(1):54-66.

PMID: 38706103 PMC: 11661946. DOI: 10.1093/schbul/sbae050.


Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis.

Wannan C, Nelson B, Addington J, Allott K, Anticevic A, Arango C Schizophr Bull. 2024; 50(3):496-512.

PMID: 38451304 PMC: 11059785. DOI: 10.1093/schbul/sbae011.


Developmental perspectives on the origins of psychotic disorders: The need for a transdiagnostic approach.

Walker E, Aberizk K, Yuan E, Bilgrami Z, Ku B, Guest R Dev Psychopathol. 2024; 36(5):2559-2569.

PMID: 38406831 PMC: 11345878. DOI: 10.1017/S0954579424000397.


Psychosis superspectrum I: Nosology, etiology, and lifespan development.

Jonas K, Cannon T, Docherty A, Dwyer D, Gur R, Gur R Mol Psychiatry. 2024; 29(4):1005-1019.

PMID: 38200290 PMC: 11385553. DOI: 10.1038/s41380-023-02388-2.


Multi-trajectories of triglyceride-glucose index and lifestyle with Cardiovascular Disease: a cohort study.

Zhou H, Ding X, Lan Y, Chen S, Wu S, Wu D Cardiovasc Diabetol. 2023; 22(1):341.

PMID: 38093279 PMC: 10720233. DOI: 10.1186/s12933-023-02076-z.


References
1.
Verma S, Subramaniam M, Abdin E, Poon L, Chong S . Symptomatic and functional remission in patients with first-episode psychosis. Acta Psychiatr Scand. 2012; 126(4):282-9. DOI: 10.1111/j.1600-0447.2012.01883.x. View

2.
Lee T, Kim S, Correll C, Byun M, Kim E, Jang J . Symptomatic and functional remission of subjects at clinical high risk for psychosis: a 2-year naturalistic observational study. Schizophr Res. 2014; 156(2-3):266-71. DOI: 10.1016/j.schres.2014.04.002. View

3.
Addington J, Stowkowy J, Liu L, Cadenhead K, Cannon T, Cornblatt B . Clinical and functional characteristics of youth at clinical high-risk for psychosis who do not transition to psychosis. Psychol Med. 2018; 49(10):1670-1677. DOI: 10.1017/S0033291718002258. View

4.
Addington J, Cadenhead K, Cannon T, Cornblatt B, McGlashan T, Perkins D . North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research. Schizophr Bull. 2007; 33(3):665-72. PMC: 2526151. DOI: 10.1093/schbul/sbl075. View

5.
Fusar-Poli P, Rocchetti M, Sardella A, Avila A, Brandizzi M, Caverzasi E . Disorder, not just state of risk: meta-analysis of functioning and quality of life in people at high risk of psychosis. Br J Psychiatry. 2015; 207(3):198-206. DOI: 10.1192/bjp.bp.114.157115. View